Investors Should Take Note Of G1 Therapeutics Inc (GTHX)

G1 Therapeutics Inc (GTHX) concluded trading on Wednesday at a closing price of $3.33, with 5.02 million shares of worth about $16.71 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 95.88% during that period and on on Wednesday the price saw a gain […]

G1 Therapeutics Inc (NASDAQ: GTHX): Hunting Genuine Value In Market Debris

Currently, there are 51.50M common shares owned by the public and among those 42.75M shares have been available to trade. Insiders at the company have transacted a total of 22 times over the past 12 months, according to data filed with the U.S. Securities and Exchange Commission (SEC). 16 of these insider trades were purchases, […]

G1 Therapeutics Inc (NASDAQ: GTHX) Is Getting Increasingly Hard To Ignore

Millennium Management LLC recently announced the acquisition of new stake in G1 Therapeutics Inc (NASDAQ:GTHX). The institutional investor has increased its shareholding in the Healthcare company by 72.51% to 1.05 million shares with purchase of 0.44 million shares. This fresh investment now brings its stake to 2.03% valued currently at $1.73 million. In addition, Raymond […]

Growth Story Still Intact For G1 Therapeutics Inc (GTHX)

Millennium Management LLC has recently announced that it has increased stake in G1 Therapeutics Inc (NASDAQ:GTHX) by 72.51%. After grabbing 1.05 million shares, the institutional investor is now in possession of 0.44 million shares of the Healthcare Company. The new investment brought the stake of investor firm to 2.03% having worth around $1.73 million. Moreover, […]